These Companies Merged To Create A Fully Integrated Cannabis Giant With International Reach

Atlas Global Brands Inc. (formerly Silver Phoenix Resources Inc.) successfully completed its business combination, pursuant to a reverse take-over transaction, with each of Atlas Biotechnologies Inc., AgMedica Bioscience Inc. and Cambrosia Ltd. and the concurrent acquisition by Cambrosia of each of Tlalim Pappo Ltd., Pharmacy Baron Ltd., and R.J. Regavim Ventures Ltd., privately held operating cannabis pharmacies in Israel, all to form Atlas Global Brands Inc. The RTO transaction constitutes a "fundamental change" of Silver Phoenix pursuant to the policies of the Canadian Securities Exchange.

The RTO transaction was completed pursuant to the terms of conditions of the amalgamation and share exchange agreement dated July 14, 2022, as amended, among Silver Phoenix, Atlas Biotech, AgMedica, Cambrosia, 2432998 Alberta Ltd. (“Subco 1”), 14060407 Canada Inc. (“Subco 2”) and the ordinary shareholders of Cambrosia.

Concurrently, with the completion of the transaction, Cambrosia completed a financing pursuant to which it issued of 100 million ordinary shares of Cambrosia with S.H.R. Group Management (KSN) Ltd. for gross proceeds of ILS 9 million ($2.5 million) with a further commitment of ILS 6 million to finance future acquisitions.

The company expects to commence trading on the CSE on or about January 13, 2023, under the ticker symbol “ATL”.

Reconstituted Management Team and Board

  • Sheldon Croome, interim CEO

  • Bernard Yeung, MBA, general manager, head of global operations

  • Jason Cervi, CPA, head of finance and administration

  • Jeffrey R. Gossain, P. Eng., COO

  • Dr. Trevor Henry, DVM, director and president of AgMedica

  • Peter Van Mol, CPA, CA, director and CFO of AgMedica

  • Cale Alacer, P.Eng, PMP, director

  • Elan MacDonald, ICD.D, director

Advisory Board

  • Jonathan Ben-Cnaan, vice chairman of the advisory board

  • Dr. Tamir Gedo, PhD, executive chairman of the advisory board

  • Professor Itamar Grotto, advisor

  • David Pappo, advisor

  • Iftach Seri, advisor

Get your daily dose of cannabis news on Benzinga Cannabis. Don’t miss out on any important developments in the industry.

Photo: Benzinga edit with photos by geralt and lindsayfox on Pixabay

 

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisM&ANewsMarketsAgMedica BioscienceAtlas BiotechnologiesAtlas Global BrandsBernard YeungCale AlacerCambrosiaDavid PappoElan MacDonaldIftach SeriItamar GrottoJason CerviJeffrey R. GossainJonathan Ben-CnaanPeter Van MolPharmacy BaronpremiumR.J. Regavim VenturesS.H.R. Group ManagementSheldon CroomeSilver Phoenix ResourcesTamir GedoTlalim PappoTrevor Henry
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.


Loading...